Sign In
Buy FLGT
$16.55
-3.66 (-18.11%)
At Close: Jul 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
05:07pm, Thursday, 05'th Mar 2026
NEW YORK, March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT). Such investors are advised t
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Rating of “Hold” by Brokerages
04:14am, Wednesday, 04'th Mar 2026
Shares of Fulgent Genetics, Inc. (NASDAQ: FLGT - Get Free Report) have been assigned an average rating of "Hold" from the five brokerages that are presently covering the stock, MarketBeat Ratings repo
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
04:34pm, Tuesday, 03'rd Mar 2026
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT). Such investors
Fulgent Genetics Q4 Earnings Call Highlights
05:05am, Monday, 02'nd Mar 2026
Fulgent Genetics (NASDAQ: FLGT) used its fourth-quarter and full-year 2025 earnings call to outline continued growth in its laboratory services business, accelerating investments in digital pathology
Fulgent Genetics, Inc. (FLGT) Q4 2025 Earnings Call Transcript
06:07pm, Friday, 27'th Feb 2026
Fulgent Genetics, Inc. (FLGT) Q4 2025 Earnings Call Transcript
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates
09:16am, Friday, 27'th Feb 2026
Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.04 per share a year ago.
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results
07:00am, Friday, 27'th Feb 2026
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a th
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
07:30am, Thursday, 12'th Feb 2026
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a the
Fulgent Genetics (NASDAQ:FLGT) & PPJ Enterprise (OTCMKTS:PPJE) Head to Head Survey
01:24am, Saturday, 07'th Feb 2026
PPJ Enterprise (OTCMKTS:PPJE - Get Free Report) and Fulgent Genetics (NASDAQ: FLGT - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two
Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock
03:59am, Tuesday, 27'th Jan 2026
Fulgent Genetics offers a fortress balance sheet, zero debt, and net assets near the current share price, providing downside protection. FLGT's diagnostics business is growing, with 15.4% revenue grow
SG Americas Securities LLC Purchases New Position in Fulgent Genetics, Inc. $FLGT
04:56am, Sunday, 25'th Jan 2026
SG Americas Securities LLC acquired a new position in Fulgent Genetics, Inc. (NASDAQ: FLGT) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commissio
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Average Rating of “Moderate Buy” from Analysts
05:44am, Sunday, 18'th Jan 2026
Fulgent Genetics, Inc. (NASDAQ: FLGT - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five brokerages that are covering the firm, MarketBeat Ratings reports. One equ
New Strong Buy Stocks for January 12th
06:55am, Monday, 12'th Jan 2026
ERO, NU, KSS, FLGT and BODI have been added to the Zacks Rank #1 (Strong Buy) List on Jan.12, 2026.
Contrasting Bullfrog AI (NASDAQ:BFRG) & Fulgent Genetics (NASDAQ:FLGT)
02:10am, Friday, 02'nd Jan 2026
Bullfrog AI (NASDAQ: BFRG - Get Free Report) and Fulgent Genetics (NASDAQ: FLGT - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two co
Analyzing Careview Communications (OTCMKTS:CRVW) & Fulgent Genetics (NASDAQ:FLGT)
01:46am, Thursday, 25'th Dec 2025
Careview Communications (OTCMKTS:CRVW - Get Free Report) and Fulgent Genetics (NASDAQ: FLGT - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the tw
